Visa agrees to pay $2.4 billion for BioCatch, putting a fraud vendor inside the card network that banks also negotiate with

Visa said Monday it will buy BioCatch, the behavioral fraud detection company used by a large slice of U.S. retail banking, in an all-cash deal worth $2.4 billion. For high-risk payment teams, the interesting part is not just the price tag: once the deal closes, a fraud vendor used by big banks will sit inside the same card network those banks use for processing and commercial negotiations.

1. Visa signed a definitive agreement to acquire BioCatch from funds advised by Permira and other shareholders. The deal is all cash and still needs regulatory approval. Visa expects it to close by the end of March 2027.
2. BioCatch does not inspect card transactions in the usual sense. It monitors how users interact with banking apps and login portals, including keystrokes, touch gestures, phone orientation, and transfer requests, and says its software reads more than 3,000 signals as a customer uses a banking app. The company says it looks for account takeovers, scams, money mules, and fake account applications.
3. The vendor is already embedded across much of U.S. retail banking. BioCatch said in a January press release that Wells Fargo signed on in 2025, bringing the total to three of the four largest U.S. banks by assets. Visa said BioCatch protects 760 million users, serves more than 350 banking clients, and analyzes 19 billion sessions a month. Visa’s announcement and Permira’s announcement repeat those counts; neither set has been independently verified.
4. After the deal closes, the same banks that buy BioCatch’s fraud tooling will also be negotiating with Visa over card terms. Eric Grover of Intrepid Ventures put the economics bluntly: bundling works for a bank “until it doesn’t,” because it simplifies vendor management and is more efficient, “albeit at the cost of reducing banks’ negotiating leverage.”
5. Visa said BioCatch will help clients “stop fraud before it reaches the point of payment.” The catch is that the U.S. interbank sharing network BioCatch runs abroad does not yet exist in the U.S.; for now, the legal basis for such a network remains a Treasury Department fact sheet that has not been reviewed by any court.

For PSPs, acquirers, and banks serving higher-risk merchants, this is a clean example of the industry’s favorite structure: one vendor, more data, less friction. It can also narrow bargaining room fast, especially when the vendor sits closer to the network than the bank would like.